Relationship among HbA1c and Lipid Profile in Punajbi Type 2 Diabetic Population

The diabetes mellitus is becoming more and more prevalent in Indian society. In India, it is estimated that approximately 2% of the population, 15 million people have diabetes (Swami, 1984). The number of cases is said to be rising by 5%-6% each year and an estimated 300,000 people die from diabetes and its complication (Herman et al., 1984). There are about 3.5 crore diabetics in India and the figure will rise to about 5.2 crores by 2025. Every 5 th

[1]  Yasemin Uslu,et al.  Glycemic control, oxidative stress, and lipid profile in children with type 1 diabetes mellitus. , 2004, Archives of medical research.

[2]  I. Goldberg.  Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. , 1996, Journal of lipid research.

[3]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[4]  G. Reaven,et al.  Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease , 1994, Diabetologia.

[5]  A. Sharrett,et al.  HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. , 2006, Diabetes care.

[6]  D. Goldstein,et al.  Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.

[7]  H. Khan,et al.  Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia , 2007, Clinical and Experimental Medicine.

[8]  S M Teutsch,et al.  An Epidemiologic Model for Diabetes Mellitus: Incidence, Prevalence, and Mortality , 1984, Diabetes Care.

[9]  Toxicity of hyperglycaemia in type 2 diabetes. , 1998, Diabetes/metabolism reviews.

[10]  E. Windler.  What is the consequence of an abnormal lipid profile in patients with type 2 diabetes or the metabolic syndrome? , 2005, Atherosclerosis. Supplements.

[11]  N. Wareham,et al.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) , 2001, BMJ : British Medical Journal.

[12]  G. Dagenais,et al.  Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. , 1998, JAMA.

[13]  S M Grundy,et al.  Multifactorial causation of obesity: implications for prevention. , 1998, The American journal of clinical nutrition.

[14]  D. Singer,et al.  The clinical information value of the glycosylated hemoglobin assay. , 1984, The New England journal of medicine.

[15]  M. Moore.  Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease. , 1998, Journal of insurance medicine.

[16]  J. Meigs,et al.  Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. , 2005, Diabetes care.